Advanced Medical Solutions Group plc
AMS.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £1 | £1 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £0 | £0 | £0 | £1 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | 40.7% | 1.5% | 14.5% | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 46.6% | 55.6% | 55.2% | 51.7% |
| EBITDA | £0 | £0 | £0 | £0 |
| % Margin | 16.7% | 24.9% | 28.1% | 29.1% |
| Net Income | £0 | £0 | £0 | £0 |
| % Margin | 4% | 12.6% | 16.4% | 16.1% |
| EPS Diluted | 0.033 | 0.073 | 0.093 | 0.08 |
| % Growth | -55.2% | -22% | 16.1% | – |
| Operating Cash Flow | £0 | £0 | £0 | £0 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | £0 | £0 | £0 | £0 |